Ingenito Gary's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Mar 7, 2025
- Accession no.
- 0001161697-25-000089
- Filed
- Mar 7, 2025
- Trade date
- Mar 5-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.89M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ingenito GaryCIK 0001279473 | Officer (Chief Med. & Reg. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +44,904 | $2.24 | +$100,584.96 | 113,777 | Direct | |
| Mar 5, 2025 | Common stock, par value $0.001 per share | SSaleDisposed | −44,904 | $22.09 | −$991,929.36 | 68,873 | Direct | |
| Mar 6, 2025 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +180,096 | $2.24 | +$403,415.04 | 248,969 | Direct | |
| Mar 6, 2025 | Common stock, par value $0.001 per share | SSaleDisposed | −180,096 | $21.67 | −$3,902,680.32 | 68,873 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common Stock | MOption exerciseDisposed | −44,904 | $0.00 | $0 | 970,378 | Direct | |
| Mar 6, 2025 | Common Stock | MOption exerciseDisposed | −180,096 | $0.00 | $0 | 790,282 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.